AI & Technical question

Before launching a new AI-native product category on top of a nascent model capability, how would you assess upside versus safety and reliability risk? Walk through your go/no-go framework, key tradeoffs, and the metrics or evals you would require before launch.

Practice this question out loud. An AI interviewer asks it, follows up like a real interviewer would, and scores your answer. Type or speak.

What this question tests

Ability to build a disciplined go or no go framework for a new product category built on unproven model capability.

Define the upside case concretely: the specific new user need this capability could serve and a reasonable estimate of its market size or strategic value, avoiding a vague this could be big.
Define the risk case concretely: what happens when the nascent capability fails in this new context, and whether failures are recoverable or hard to reverse.
Require a minimum eval bar before launch, a defined reliability threshold on tasks representative of the new category, plus red teaming for failure modes this category introduces that existing evals do not cover.
Weigh the tradeoff explicitly: a new category carries more uncertainty than extending an existing one, so the evidence bar should be higher and a staged launch preferred over a full one.
Set the go or no go decision on whether upside justifies risk given the eval results, not enthusiasm alone, leaning toward a narrow beta if evidence is promising but incomplete.
Define the specific metrics you would monitor post launch to catch a risk evals missed, since a new category has little real world precedent to predict from.

Requires a concrete reliability eval threshold and category specific red teaming, not reuse of an unrelated existing eval suite.
Weighs consequence and reversibility of failure explicitly, not just probability of failure.
Chooses a staged or limited launch as the default when evidence is promising but not conclusive, rather than a binary full launch or nothing.
Names concrete post launch monitoring metrics because a new category has limited precedent to predict risk from.

Reusing an eval suite built for a different, more established product category and assuming it covers the new risks.
Treating the decision as binary, full launch or nothing, instead of considering a staged rollout given the uncertainty.

What would you do if evals looked good but you had low confidence in their representativeness?
How would you decide when a staged beta has gathered enough evidence to go to full launch?